The new Waqf bill, Manish Sisoda's bail, and waiver for clinical trials
3 Things
Expedited Drug Approvals in India
This chapter examines a new order from India's drug regulator allowing certain international drugs to enter the Indian market without local clinical trials. It discusses the implications for drug safety and efficacy, the categories of drugs affected, and the factors influencing their success in diverse populations.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
